Moderate choline intake lowers heart disease risk

FHS
June 5, 2024
12:35 am

A recent study from BMC Public Health found that moderate dietary choline intake is associated with a reduced risk of atherosclerotic cardiovascular disease (ASCVD) among US adults.

BMS and Prime ink potential $3.5bn deal to develop T cell therapies – Pharmaceutical Technology

Ex vivo gene therapy offers a potential one-time, curative solution for a host of genetic diseases. Image: Getty Images/ Perception7 Bristol Myers Squibb (BMS) has

October 1, 2024

Abbott CEO talks diabetes market, device pricing at J.P. Morgan conference

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Abbott CEO Robert Ford expects the company

January 10, 2024

Yeast-fermented bread shows promise in preventing asthma symptoms

The effects of a functional bread fermented with yeast (Saccharomyces cerevisiae) in asthma prevention.

June 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.